Croda International
LSE:CRDA Community- 1 Narratives written by author
- 0 Comments on narratives written by author
- 14 Fair Values set on narratives written by author
WA
Consensus Narrative from 15 Analysts
Acquisition Of Solus Biotech And Asian Expansion Will Strengthen Future Outlook
Key Takeaways Strengthening local relationships and strategic acquisitions, particularly in Asia, should drive revenue through higher prices and increased manufacturing capacity. Targeting innovation and operational efficiencies, with a focus on mRNA products, positions Croda for growth in both consumer and pharma markets.
View narrativeUK£41.72
FV
21.8% undervalued intrinsic discount5.59%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
3 days ago author updated this narrative